Boston Scientific · 1 month ago
Sector Business Strategist, Cardiology
Boston Scientific is a leader in medical science committed to solving health industry challenges. The Sector Business Strategist (SBS) will partner with the VP of Sales to drive sector execution and strategic alignment while analyzing performance data to inform actionable strategies.
Health CareMedicalMedical Device
Responsibilities
Act as a proxy for the VP of Sales in driving execution and accountability across the sector
Respond to ad hoc strategic requests from Area Vice Presidents (AVPs) and Regional Directors (RDs), including direct outreach to understand market dynamics
Drive sector insights by analyzing performance data and translating findings into clear, actionable strategies
Investigate root causes of performance gaps and collaborate with sector teams to implement solutions
Maintain visibility into the Top 10 accounts nationally, providing analysis on performance drivers and strategic opportunities
Collect and synthesize feedback from the field to inform sector strategy and leadership decision-making
Partner with Marketing and other functions to support execution of sector-specific initiatives and campaigns
Provide hands-on support during quarter-end close, both at the sector and national level
Lead and document process improvement efforts to streamline quarter-end operations for future cycles
Track and follow up on training enrollments, readiness issues, and execution blockers
Qualification
Required
Experience in business strategy, operations, or analytics, preferably in a sales-driven environment
Strong communication skills with the ability to represent senior leadership and influence cross-functional teams
Analytical mindset with proficiency in data tools and storytelling
Highly organized and action-oriented, with the ability to manage multiple priorities
Minimum of 5 years' field sales experience
Preferred
Experience in healthcare, life sciences, or a related sector
Company
Boston Scientific
Boston Scientific is a medical technology company that designs and develops medical devices to diagnose and treat a wide range of condition.
Funding
Current Stage
Public CompanyTotal Funding
$10.02B2025-02-21Post Ipo Debt· $1.58B
2024-02-22Post Ipo Debt· $2.17B
2022-03-04Post Ipo Debt· $3.28B
Recent News
2026-01-24
2026-01-23
Company data provided by crunchbase